Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease

Veterinary Immunology and Immunopathology

Volumn 158, Issue 3-4, 2014, Pages 156-166

  Heilmann, Romy M ^a   Grellet, Aurélien ^b   Allenspach, Karin ^c   Lecoindre, Patrick ^d   Day, Michael J ^e   Priestnall, Simon L ^c   Toresson, Linda ^f   Procoli, Fabio ^c   Grützner, Niels ^a   Suchodolski, Jan S ^a   Steiner, Jörg M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Royal Canin Research Center   (France)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

^d CLINIQUE VÉTÉRINAIRE   (France)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f Helsingborg Referral Animal Hospital   (Sweden)

Author keywords

Biomarker; Calgranulin; Canine; Inflammation

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; COBALAMIN; GLUCOCORTICOID; S100A12 PROTEIN; UNCLASSIFIED DRUG; PROTEIN S 100; PROTEIN; PROTEIN S100A12;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; COLON; COLONOSCOPY; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOG; DUODENUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FECES ANALYSIS; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HYPOALBUMINEMIA; IDIOPATHIC DISEASE; IDIOPATHIC INFLAMMATORY BOWEL DISEASE; INFLAMMATORY BOWEL DISEASE; LAMINA PROPRIA; MACROPHAGE; MELENA; NEUTROPHIL; NONHUMAN; POLYDIPSIA; RECTUM HEMORRHAGE; VOMITING; WEIGHT REDUCTION; ANIMAL; CASE CONTROL STUDY; CHEMISTRY; DOG DISEASES; FECES; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASES; MALE; PATHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; VETERINARY; ANIMAL MODEL; CLINICAL DISEASE ACTIVITY INDEX; ENDOSCOPY; ENTEROPATHY; HISTOLOGY; HYPOPROTEINEMIA; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

CANIS FAMILIARIS;

ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; RETROSPECTIVE STUDIES; S100 PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 84897077334     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2014.01.006     Document Type: Article

References (30)

1. Allenspach K., Wieland B., Gröne A., Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J. Vet. Intern. Med. 2007, 21:700-708.
2. Berghoff N., Parnell N.K., Hill S.L., Suchodolski J.S., Steiner J.M. Serum cobalamin and methylmalonic acid concentrations in dogs with chronic gastrointestinal disease. Am. J. Vet. Res. 2013, 74:84-89.
3. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83:876-886.
4. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., Moher D., Rennie D., de Vet H.C., Lijmer J.G. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem. 2003, 49:7-18.
5. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., Lijmer J.G., Moher D., Rennie D., de Vet H.C. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Radiology 2003, 226:24-28.
6. Burgener I.A., König A., Allenspach K., Sauter S.N., Boisclair J., Doherr M.G., Jungi T.W. Upregulation of toll-like receptors in chronic enteropathies in dogs. J. Vet. Intern. Med. 2008, 22:553-560.
7. Casamian-Sorrosal D., Willard M.D., Murray J.K., Hall E.J., Taylor S.S., Day M.J. Comparison of histopathologic findings in biopsies from the duodenum and ileum of dogs with enteropathy. J. Vet. Intern. Med. 2010, 24:80-83.
8. Day M.J., Bilzert T., Mansell J., Wilcock B., Hall E.J., Jergens A.E., Minami T., Willard M.D., Washabau R.J. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the world small animal veterinary association gastrointestinal standardization group. J. Comp. Pathol. 2008, 138:1-40.
9. Foell D., Kucharzik T., Kraft M., Vogl T., Sorg C., Domschke W., Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003, 52:847-853.
10. Foell D., Wittkowski H., Ren Z., Turton J., Pang G., Däbritz J., Ehrchen J., Heidemann J., Borody T., Roth J., Clancy R. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J. Pathol. 2008, 216:183-192.
11. Foell D., Wittkowski H., Roth J. Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut 2009, 58:859-868.
12. Fuellen G., Nacken W., Sorg C., Kerkhoff C. Computational searches for missing orthologs: the case of S100A12 in mice. OMICS 2004, 8:334-340.
13. Garcia-Sancho M., Rodriguez-Franco F., Sainz A., Mancho C., Rodriquez A. Evaluation of clinical, macroscopic, and histopathologic response to treatment in nonhypoproteinemic dogs with lymphocytic-plasmacytic enteritis. J. Vet. Intern. Med. 2007, 21:11-17.
14. Heilmann R.M., Suchodolski J.S., Steiner J.M. Development and analytic validation of a radioimmunoassay for the quantification of canine calprotectin in serum and feces from dogs. Am. J. Vet. Res. 2008, 69:845-853.
15. Heilmann R.M., Suchodolski J.S., Steiner J.M. Purification and partial characterization of canine S100A12. Biochimie 2010, 92:1914-1922.
16. Heilmann R.M., Allenspach K., Procoli F., Weber K., Suchodolski J.S., Steiner J.M. Serum calgranulin concentrations in dogs with inflammatory bowel disease. J. Vet. Intern. Med. 2011, 25(6):1486. (abstract).
17. Heilmann R.M., Lanerie D.J., Ruaux C.G., Grützner N., Suchodolski J.S., Steiner J.M. Development and analytic validation of an immunoassay for the quantification of canine S100A12 in serum and fecal samples and its biological variability in serum from healthy dogs. Vet. Immunol. Immunopathol. 2011, 144:200-209.
18. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
19. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979, 6:64-70.
20. Kaiser T., Langhorst J., Wittkowski H., Becker K., Friedrich A.W., Rueffer A., Dobos G.J., Roth J., Foell D. Fecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 2007, 56:1706-1713.
21. Kathrani A., Holder A., Catchpole B., Alvarez L., Simpson K., Werling D., Allenspach K. TLR5 risk-associated haplotype for canine inflammatory bowel disease confers hyperresponsiveness to flagellin. PLoS ONE 2012, 7:e30117.
22. Luckschander N., Hall J.A., Gaschen F.P., Forster U., Wenzlow N., Hermann P., Allenspach K., Dobbelaere D., Burgener I.A., Welle M. Activation of nuclear factor-kappaB in dogs with chronic enteropathies. Vet. Immunol. Immunopathol. 2010, 13:228-236.
23. Mandigers P.J., Biourge V., van den Ingh T.S., Ankringa N., German A.J. A randomized, open-label, positively-controlled field trial of a hydrolyzed protein diet in dogs with chronic small bowel enteropathy. J. Vet. Intern. Med. 2010, 24:1350-1357.
24. McMahon L.A., House A.K., Catchpole B., Elson-Riggins J., Riddle A., Smith K., Werling D., Burgener I.A., Allenspach K. Expression of Toll-like receptor 2 in duodenal biopsies from dogs with inflammatory bowel disease is associated with severity of disease. Vet. Immunol. Immunopathol. 2010, 135:158-163.
25. Pietzsch J., Hoppmann S. Human S100A12: a novel key player in inflammation?. Amino Acids 2009, 36:381-389.
26. Simpson K.W., Jergens A.E. Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease. Vet. Clin. North Am. Small Anim. 2012, 41:381-398.
27. Van de Logt F., Day A.S. S100A12: a noninvasive marker of inflammation in inflammatory bowel disease. J. Dig. Dis. 2013, 14:62-67.
28. Washabau R.J., Day M.J., Willard M.D., Hall E.J., Jergens A.E., Mansell J., Minami T., Bilzer T.W. Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. J. Vet. Intern. Med. 2010, 24:10-26.
29. Wilke V.L., Nettleton D., Wymore M.J., Gallup J.M., Demirkale C.Y., Ackermann M.R., Tuggle C.K., Ramer-Tait A.E., Wannemuehler M.J., Jergens A.E. Gene expression in intestinal mucosal biopsy specimens obtained from dogs with chronic enteropathy. Am. J. Vet. Res. 2012, 73:1219-1229.
30. Yang Z., Tao T., Raftery M., Youssef P., Di Girolamo N., Geczy C.L. Proinflammatory properties of the human S100 protein S100A12. J. Leukoc. Biol. 2001, 69:986-994.